Diagnostics & Research
The Diagnostics & Research industry has a total of 46 stocks, with a combined market cap of $865.16 billion, total revenue of $173.15 billion and a weighted average PE ratio of 48.19.
Market Cap
865.16B
Revenue
173.15B
Profits
17.95B
PE Ratio
48.19
Profit Margin
10.37%
Dividend Yield
0.20%
46 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 233.20B | -0.47% | 1,455,408 | 46.34B |
| 2 | DHR | Danaher Corporation | 151.62B | 0.15% | 2,896,780 | 25.11B |
| 3 | NTRA | Natera, Inc. | 48.82B | 0.07% | 730,980 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 44.46B | 1.68% | 3,184,194 | 7.37B |
| 5 | IQV | IQVIA Holdings Inc. | 43.19B | 0.33% | 1,225,016 | 16.98B |
| 6 | IDXX | IDEXX Laboratories, Inc. | 42.94B | -1.51% | 340,458 | 4.55B |
| 7 | WAT | Waters Corporation | 41.39B | 1.71% | 741,534 | 4.64B |
| 8 | ILMN | Illumina, Inc. | 34.38B | 1.27% | 1,937,085 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 28.20B | 0.64% | 146,040 | 4.13B |
| 10 | LH | Labcorp Holdings Inc. | 27.29B | 0.24% | 671,364 | 14.35B |
| 11 | DGX | Quest Diagnostics Incorporated | 27.00B | -0.16% | 833,312 | 11.56B |
| 12 | GH | Guardant Health, Inc. | 22.61B | -1.40% | 1,504,456 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 17.07B | -1.21% | 196,548 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 14.47B | 2.66% | 1,932,714 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 14.15B | 0.44% | 901,312 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 13.09B | 0.47% | 376,267 | 8.29B |
| 17 | TWST | Twist Bioscience Corporation | 9.60B | 2.03% | 1,252,240 | 431.80M |
| 18 | QGEN | Qiagen N.V. | 9.05B | 0.88% | 1,582,318 | 2.10B |
| 19 | RDNT | RadNet, Inc. | 5.93B | -1.45% | 528,463 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.56B | -0.31% | 1,775,422 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.49B | -1.11% | 670,064 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.22B | 1.07% | 2,078,789 | 308.08M |
| 23 | GRAL | GRAIL, Inc. | 3.68B | 3.66% | 742,897 | 165.26M |
| 24 | VCYT | Veracyte, Inc. | 3.64B | 2.17% | 1,243,377 | 561.90M |
| 25 | CDNA | CareDx, Inc. | 2.71B | 2.75% | 1,250,756 | 458.09M |
| 26 | WGS | GeneDx Holdings Corp. | 2.66B | -1.16% | 354,189 | 454.43M |
| 27 | NEO | NeoGenomics, Inc. | 2.39B | 7.31% | 5,097,628 | 766.30M |
| 28 | PSNL | Personalis, Inc. | 1.79B | -1.64% | 4,881,359 | 69.67M |
| 29 | FRNM | Freenome, Inc. | 1.50B | -1.06% | 348,684 | 35.41M |
| 30 | OPK | OPKO Health, Inc. | 1.12B | -0.66% | 2,709,939 | 587.90M |
| 31 | CSTL | Castle Biosciences, Inc. | 1.05B | 0.53% | 251,211 | 357.28M |
| 32 | FLGT | Fulgent Genetics, Inc. | 548.93M | 0.71% | 212,518 | 323.93M |
| 33 | MYGN | Myriad Genetics, Inc. | 304.17M | 1.92% | 1,112,716 | 806.60M |
| 34 | BDSX | Biodesix, Inc. | 300.50M | -6.93% | 162,312 | 102.94M |
| 35 | XGN | Exagen Inc. | 182.17M | -1.96% | 161,653 | 71.12M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 140.39M | -0.23% | 36,298 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 123.58M | 6.91% | 884,862 | 537.08K |
| 38 | BNR | Burning Rock Biotech Limited | 105.46M | -4.21% | 6,262 | 74.58M |
| 39 | MDXH | MDxHealth SA | 68.84M | -4.58% | 270,908 | 114.02M |
| 40 | PRPO | Precipio, Inc. | 52.43M | -3.67% | 36,684 | 27.20M |
| 41 | ADVB | Advanced Biomed Inc. | 15.81M | 3.57% | 371,741 | - |
| 42 | XWEL | XWELL, Inc. | 8.51M | -0.56% | 23,659 | 28.28M |
| 43 | NDRA | ENDRA Life Sciences Inc. | 8.11M | -0.64% | 9,848 | - |
| 44 | MBAI | Check-Cap Ltd. | 7.49M | -3.10% | 14,890 | - |
| 45 | ISPC | iSpecimen Inc. | 4.03M | -2.44% | 62,896 | 466.30K |
| 46 | BIAF | bioAffinity Technologies, Inc. | 2.73M | -0.59% | 42,448 | 5.90M |